Suppr超能文献

恢复期血清衍生的外泌体:作为 COVID-19 诊断工具和 mRNA 递送载体的有吸引力的研究领域。

Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery.

机构信息

Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa.

Department of Chemical Pathology, School of Pathology, National Health Laboratory Services, Bloemfontein 9301, South Africa.

出版信息

Exp Biol Med (Maywood). 2022 Jul;247(14):1244-1252. doi: 10.1177/15353702221092984. Epub 2022 May 13.

Abstract

The spread of SARS-CoV-2 over the entire world is more commonly known as COVID-19. COVID-19 has impacted society in every aspect of routine life. SARS-CoV-2 infection is often misdiagnosed as influenza or seasonal upper respiratory tract viral infections. General diagnostic tools can detect the viral antigen or isotypes of antibodies. However, inter- and intraindividual variations in antibody levels can cause false negatives in antibody immunoassays. On the contrary, the false-positive test results can also occur due to either cross-reactivity of the viral antigens or some other patient-related autoimmune factors. There is need for a cogent diagnostic tool with more specificity, selectivity, and reliability. Here, we have described the potential of convalescent serum-derived exosome as a diagnostic tool for the detection of SARS-CoV-2, even in asymptomatic patients, which is a limitation for currently practiced diagnostic tests throughout the globe. In addition, its potential as a vehicle for messenger RNA (mRNA) delivery is also emphasized.

摘要

SARS-CoV-2 在全球范围内的传播通常被称为 COVID-19。COVID-19 对日常生活的各个方面都产生了影响。SARS-CoV-2 感染常被误诊为流感或季节性上呼吸道病毒感染。一般的诊断工具可以检测病毒抗原或抗体同种型。然而,抗体水平的个体内和个体间差异会导致抗体免疫测定出现假阴性。相反,由于病毒抗原的交叉反应或其他与患者相关的自身免疫因素,也会出现假阳性的测试结果。因此,我们需要一种更具特异性、选择性和可靠性的有效诊断工具。在这里,我们描述了恢复期血清衍生的外泌体作为一种诊断工具检测 SARS-CoV-2 的潜力,即使是在无症状患者中,这是目前全球实践诊断测试的一个局限性。此外,还强调了其作为信使 RNA(mRNA)传递载体的潜力。

相似文献

4
The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients.血清特异性 SARS-CoV-2 抗体在 COVID-19 患者中的作用。
Int Immunopharmacol. 2021 Feb;91:107325. doi: 10.1016/j.intimp.2020.107325. Epub 2020 Dec 24.

引用本文的文献

3
Exosomes: a promising avenue for cancer diagnosis beyond treatment.外泌体:癌症诊断中超越治疗的一条有前景的途径。
Front Cell Dev Biol. 2024 Feb 13;12:1344705. doi: 10.3389/fcell.2024.1344705. eCollection 2024.
6
8
Nanoparticle-Based Delivery Systems for Vaccines.基于纳米颗粒的疫苗递送系统
Vaccines (Basel). 2022 Nov 17;10(11):1946. doi: 10.3390/vaccines10111946.

本文引用的文献

1
COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals.COVAX-19Ⓡ疫苗:完全阻断病毒向未免疫个体的传播。
Clin Complement Med Pharmacol. 2021 Dec;1(1):100004. doi: 10.1016/j.ccmp.2021.100004. Epub 2021 Aug 9.
2
A global picture: therapeutic perspectives for COVID-19.全球视角:COVID-19 的治疗展望。
Immunotherapy. 2022 Apr;14(5):351-371. doi: 10.2217/imt-2021-0168. Epub 2022 Feb 21.
3
Covid-19 mRNA Vaccines - Six of One, Half a Dozen of the Other.新冠病毒mRNA疫苗——半斤八两。
N Engl J Med. 2022 Jan 13;386(2):183-185. doi: 10.1056/NEJMe2117446. Epub 2021 Dec 1.
5
The tangled history of mRNA vaccines.信使核糖核酸疫苗的复杂历史。
Nature. 2021 Sep;597(7876):318-324. doi: 10.1038/d41586-021-02483-w.
6
Lipid nanoparticles for mRNA delivery.用于mRNA递送的脂质纳米颗粒。
Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验